Scientific Advisory Board

The Scientific Advisory Board (SAB) is comprised of many notable scientists including the researcher who isolated the first Alzheimer’s gene, a scientist who helped decipher the genetic code, and two Nobel laureates. The SAB provides guidance to the Institute’s research program and assistance in forging alliances with institutions and companies around the world. 


Rudolph Tanzi, Ph.D. - Chairman
Director, Genetics and Aging Unit
MassGeneral Institute for Neurodegenerative Disease
Massachusetts General Hospital

Floyd E. Bloom, M.D.

Chairman and Chief Executive Officer

Neurome, Inc.

The Scripps Research Institute

Louis J. De Felice, Ph.D.

Professor of Physiology and Biophysics

Virginia Commonwealth University

Toshio Narahashi, Ph.D.

John Evans Professor of Pharmacology

Department of Molecular Pharmacology and Biological Chemistry

Northwestern University Feinberg School of Medicine

T.W. Robbins, FRS

Professor
Department of Experimental Psychology
University of Cambridge

Peter J.S. Smith, Ph.D.

Senior Scientist & Director

Program in Molecular Physiology

Marine Biological Laboratory

Juan C. Troncoso, M.D.

The Johns Hopkins Medical Institutions

Department of Pathology

Division of Neuropathology

Paul A. Wender

Bergstrom Professor of Chemistry

Department of Chemistry

Professor of Chemical and Systems Biology (by courtesy)

Stanford Medical School

Stanford University

Daniel A. Alkon, M.D., ex officio

Scientific Director

Blanchette Rockefeller Neurosciences Institute